• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有溶骨性病变的佩吉特病:药物治疗与手术治疗相结合

Paget's disease with osteolytic lesions: combining medical and surgical treatments.

作者信息

Brumsen C, Bloem R M, Papapoulos S E

机构信息

Department of Endocrinology, University Hospital, Leiden, Netherlands.

出版信息

Neth J Med. 1992 Jun;40(5-6):292-8.

PMID:1436268
Abstract

A patient with extensive Paget's disease of bone presented with severe bone pain, hypercalcaemia and a large osteolytic lesion of the femur which developed during long-term therapy with etidronate. Treatment with pamidronate normalized serum calcium concentration and induced a complete biochemical remission. The osteolytic lesion was grafted with bone chips. A recurrence of the Paget's disease was associated with clear autonomous hypercalcaemic hyperparathyroidism. Five years after removal of 3 1/2 hyperplastic parathyroid glands, the patient remains in complete clinical and biochemical remission. These findings illustrate the pitfalls encountered in the management of Paget's disease and the value of combining medical and surgical interventions.

摘要

一名患有广泛骨Paget病的患者出现严重骨痛、高钙血症以及在长期依替膦酸治疗期间发生的股骨大溶骨性病变。帕米膦酸治疗使血清钙浓度恢复正常并诱导了完全的生化缓解。对溶骨性病变进行了骨屑移植。Paget病复发与明确的自主性高钙血症性甲状旁腺功能亢进相关。在切除3个半增生的甲状旁腺腺体5年后,患者仍处于完全的临床和生化缓解状态。这些发现说明了在Paget病管理中遇到的陷阱以及联合药物和手术干预的价值。

相似文献

1
Paget's disease with osteolytic lesions: combining medical and surgical treatments.伴有溶骨性病变的佩吉特病:药物治疗与手术治疗相结合
Neth J Med. 1992 Jun;40(5-6):292-8.
2
A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.一项比较口服阿仑膦酸盐和静脉注射帕米膦酸盐治疗骨Paget病的随机临床试验。
Bone. 2004 Apr;34(4):747-54. doi: 10.1016/j.bone.2003.12.011.
3
Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates.利塞膦酸盐和帕米膦酸盐在严重骨Paget病及对双膦酸盐产生获得性耐药患者临床管理中的应用。
Calcif Tissue Int. 2004 Sep;75(3):189-96. doi: 10.1007/s00223-004-0103-3.
4
Coincidence of Paget disease of bone and primary hyperparathyroidism.骨佩吉特病与原发性甲状旁腺功能亢进症的巧合。
Sb Lek. 1993;94(3):213-7.
5
Improved treatment of Paget's disease with dimethylaminohydroxypropylidene bisphosphonate.用二甲基氨基羟丙叉双膦酸盐改善佩吉特病的治疗。
J Bone Miner Res. 1993 Feb;8(2):175-82. doi: 10.1002/jbmr.5650080208.
6
[Association between Paget's disease and primary hyperparathyroidism].佩吉特病与原发性甲状旁腺功能亢进症之间的关联
Medicina (B Aires). 1997;57(6):685-92.
7
A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.骨佩吉特病综述:聚焦5毫克唑来膦酸的疗效与安全性
Curr Med Res Opin. 2008 Mar;24(3):695-705. doi: 10.1185/030079908X260899. Epub 2008 Jan 25.
8
Management of Paget's disease of bone.骨佩吉特病的管理
Rheumatology (Oxford). 2004 Aug;43(8):955-9. doi: 10.1093/rheumatology/keh243. Epub 2004 Jun 8.
9
Successful treatment of resistant Paget's disease of bone with pamidronate.帕米膦酸盐成功治疗骨Paget病耐药病例
Arch Intern Med. 1989 Dec;149(12):2765-7.
10
Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.骨Paget病双膦酸盐治疗后的长期生化反应。建议的治疗监测间隔时间。
Rheumatology (Oxford). 2004 Jul;43(7):869-74. doi: 10.1093/rheumatology/keh185. Epub 2004 Mar 30.